ATR AND DNA-PK/CHK1 ELICIT DISTINCT RESPONSES IN CANCER CELLS

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2015年 / 5卷 / 11期
关键词：
D O I：
10.1158/2159-8290.CD-RW2015-184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1123 / 1123
页数：1
相关论文
共 50 条
  • [1] Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase
    Buisson, Remi
    Boisvert, Jessica L.
    Benes, Cyril H.
    Zou, Lee
    MOLECULAR CELL, 2015, 59 (06) : 1011 - 1024
  • [2] Chk1 and DNA-PK mediate TPEN-induced DNA damage in a ROS dependent manner in human colon cancer cells
    Rahal, Omar Nasser
    Fatfat, Maamoun
    Hankache, Carla
    Osman, Bassam
    Khalife, Hala
    Machaca, Khaled
    Muhtasib, Hala-Gali
    CANCER BIOLOGY & THERAPY, 2016, 17 (11) : 1139 - 1148
  • [3] Radiosensitizing bladder cancer cells by DNA-PK and ATR inhibitors
    Chughtai, A.
    Pannhausen, J.
    Dinger, P.
    Wirtz, J.
    Knuechel-Clarke, R.
    Gaisa, N.
    Eble, M. J.
    Rose, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S156 - S156
  • [4] ATR/CHK1 inhibitors and cancer therapy
    Qiu, Zhaojun
    Oleinick, Nancy L.
    Zhang, Junran
    RADIOTHERAPY AND ONCOLOGY, 2018, 126 (03) : 450 - 464
  • [5] Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy
    Massey, Andrew J.
    CANCER LETTERS, 2016, 383 (01) : 41 - 52
  • [6] Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer
    Liu, Kang
    Graves, Joshua D.
    Lin, Fang-Tsyr
    Lin, Weei-Chin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [7] Effective Radiosensitization of Bladder Cancer Cells by Pharmacological Inhibition of DNA-PK and ATR
    Chughtai, Ahmed Ali
    Pannhausen, Julia
    Dinger, Pia
    Wirtz, Julia
    Knuechel, Ruth
    Gaisa, Nadine T.
    Eble, Michael J.
    Rose, Michael
    BIOMEDICINES, 2022, 10 (06)
  • [8] ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells
    Ronco, Cyril
    Martin, Anthony R.
    Demange, Luc
    Benhida, Rachid
    MEDCHEMCOMM, 2017, 8 (02) : 295 - 319
  • [9] Targeting hypoxic cancer cells by inhibition of checkpoint kinases ATR and CHK1
    Joel, M.
    Hasvold, G.
    Syljuasen, R. G.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S960 - S960
  • [10] ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses
    Yang, J
    Yu, YN
    Hamrick, HE
    Duerksen-Hughes, PJ
    CARCINOGENESIS, 2003, 24 (10) : 1571 - 1580
12345